Clinical Data, Inc. Announces Approval Of Generic Name Vilazodone, First In A New Class Of Experimental Treatments For Depression
Links shared publicly online about this topic.
- 1,951total visits
Clinical Data, Inc. Announces Approval Of Generic Name Vilazodone, First In A New Class Of Experimental Treatments For Depression
Clinical Data, Inc. (NASDAQ: CLDA) announced today that the United States Adopted Name Council (USAN) has approved the generic name vilazodone hydrochloride.
View full resource at medicalnewstoday.com
Tags: Depression
Most Recently Shared on June 22, 2009 at 4:01 pm By:
Clinical Data, Inc. Announces Approval Of Generic Name Vilazodone, First In A New Class Of Experimental Treatmen.. http://tinyurl.com/laprw7
Clinical Data, Inc. Announces Approval Of Generic Name Vilazodone, First In A New Class Of Experimental Treatments For Depression | Psydir News
news.psydir.com — “Clinical data, inc. (nasdaq: clda) announced today that the united states adopted name council (usan) has approved the generic name vilazodone hydrochloride.” View full resource at news.psydir.com
Most Recently Shared on June 22, 2009 at 3:38 pm By:
Clinical Data, Inc. Announces Approval Of Generic Name Vilazodone, First In A New Class Of Experimental Treatmen.. http://bit.ly/16BTlU
Advertisement
